BiofilmX
Natural health product licensed in Canada
- Licence holder
- Vita Aid Professional Therapeutics
- NPN or DIN-HM
- 80137805
- Status
- Active licence
- Licence date
- 15 January 2025
- Revision date
- Not provided
- Form
- Capsule, libération retardée
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- À vérifier
Serratiopeptidase is listed in the Novel Food Catalogue as a novel food not yet authorised in the European Union: in the form covered by the entry, it should not be sold until authorised. The catalogue is informative; a declaration in France is not an authorisation.
POL-NF-00692. Novel Food Catalogue (status of products under Regulation (EU) 2015/2283), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Serratiopeptidase Source : Serratia marcescens E-15 - Cellule Entiière | 30,000 SPU | Not calculated |
| 1,3-bêta-D-Xylane xylanohydrolase Source : Trichoderma longibrachiatum - En entier | 1,100 XAU | Not calculated |
| Pectin pectylhydrolase Source : Aspergillus niger - En entier | 50 EPU | Not calculated |
| 1,3-(1-3,1-4)-beta-D-glucan 3(4)-glucanohydrolase Source : Trichoderma longibrachiatum - En entier | 30 FCC BGU | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Aspergillus niger - En entier | 500 FCC CU | Not calculated |
| Protéase fongique Source : Aspergillus flavus var. oryzae - En entier | 15,000 FCC HUT | Not calculated |
| 1,3-bêta-D-xylane xylanohydrolase Source : Aspergillus niger - En entier | 4,000 FCC HCU | Not calculated |
| Nattokinase Source : Glycine max - Graine | 1,400 FU | Not calculated |
| Nattokinase Source : Nattokinase | 1,400 FU | Not calculated |
| Nattokinase Source : Bacillus subtilis var. natto - Whole | 1,400 FU | Not calculated |
Non-medicinal ingredients
Maltodextrine, Hypromellose, Dextrine, Palmitate d'ascorbyle, Cellulose microcristalline, L-Leucine, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to reduce (symptoms such as) pain, quantity of secretion, inability to perceive smell and stuffy nose from ear, nose and/or throat infections. Mucolytic enzyme that helps break down mucous to reduce (symptoms such as) pain, quantity of secretion, inability to perceive smell and stuffy nose from ear, nose and/or throat infections. Mucolytic enzyme that helps break down mucous.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80137805
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.